Product nameAnti-IL-28 + IL-29 antibody [EPR14608] (HRP)
See all IL-28 + IL-29 primary antibodies
DescriptionRabbit monoclonal [EPR14608] to IL-28 + IL-29 (HRP)
Tested applicationsSuitable for: WBmore details
Species reactivityReacts with: Human
Synthetic peptide within Human IL-28 + IL-29 aa 50-150. The exact sequence is proprietary.
Database link: Q8IZJ0
- WB: Human IL28A full length (Active) protein.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Stable for 12 months at -20°C. Store In the Dark.
Storage bufferpH: 7.40
Preservative: 0.1% Proclin
Constituents: 1% BSA, 30% Glycerol, PBS
Concentration information loading...
PurityProtein A purified
Our Abpromise guarantee covers the use of ab209048 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/10000. Detects a band of approximately 20 kDa (predicted molecular weight: 22 kDa).|
RelevanceIL-29: Cytokine with immunomodulatory activity. May play a role in antiviral immunity. Up-regulates MHC class I antigen expression. Ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1. The ligand/receptor complex seems to signal through the Jak-STAT pathway. Il-28A: Cytokine with immunomodulatory activity. Up-regulates MHC class I antigen expression. Displays potent antiviral activity. Also displays antitumor activity. Ligand for the heterodimeric class II cytokine receptor composed of IL10RB and IFNLR1. The ligand/receptor complex seems to signal through the Jak-STAT pathway. Seems not to be essential for early virus-activated host defense in vaginal infection, but plays an important role in Toll-like receptor (TLR)-induced antiviral defense. Plays a significant role in the antiviral immune defense in the intestinal epithelium.
- IFNL1 antibody
- IFNL2 antibody
- Cytokine Zcyto20 antibody
Anti-IL-28 + IL-29 antibody [EPR14608] (HRP) (ab209048) at 1/10000 dilution +
Recombinant human IL-28A protein (ab50037) at 0.1 µg
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 22 kDa
Observed band size: 20 kDa why is the actual band size different from the predicted?
Exposure time: 10 seconds
This blot was produced using a 4-12% Bis-tris gel under the MES buffer system. The gel was run at 200V for 35 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% milk before being incubated with ab209048 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
ab209048 has not yet been referenced specifically in any publications.